AngioDynamics, Inc. (ANGO)
ANGO Stock Price Chart
Explore AngioDynamics, Inc. interactive price chart. Choose custom timeframes to analyze ANGO price movements and trends.
ANGO Company Profile
Discover essential business fundamentals and corporate details for AngioDynamics, Inc. (ANGO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
1 Jun 2004
Employees
748.00
Website
https://www.angiodynamics.comCEO
James C. Clemmer
Description
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
ANGO Financial Timeline
Browse a chronological timeline of AngioDynamics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 31 Mar 2026
Upcoming earnings on 6 Jan 2026
Upcoming earnings on 2 Oct 2025
EPS estimate is -$0.14, while revenue estimate is $72.69M.
Earnings released on 15 Jul 2025
EPS came in at -$0.03 surpassing the estimated -$0.13 by +76.92%, while revenue for the quarter reached $80.16M , beating expectations by +7.95%.
Earnings released on 2 Apr 2025
EPS came in at $0.03 surpassing the estimated -$0.13 by +123.08%, while revenue for the quarter reached $72.00M , missing expectations by -3.03%.
Earnings released on 8 Jan 2025
EPS came in at -$0.04 surpassing the estimated -$0.11 by +63.64%, while revenue for the quarter reached $72.85M , beating expectations by +3.23%.
Earnings released on 3 Oct 2024
EPS came in at -$0.11 surpassing the estimated -$0.15 by +26.67%, while revenue for the quarter reached $67.49M , missing expectations by -0.65%.
Earnings released on 16 Jul 2024
EPS came in at -$0.06 surpassing the estimated -$0.20 by +70.00%, while revenue for the quarter reached $70.98M , beating expectations by +0.18%.
Earnings released on 4 Apr 2024
EPS came in at -$0.16 falling short of the estimated -$0.14 by -14.29%, while revenue for the quarter reached $75.18M , missing expectations by -0.72%.
Earnings released on 5 Jan 2024
EPS came in at -$0.05 surpassing the estimated -$0.09 by +44.44%, while revenue for the quarter reached $79.07M , missing expectations by -3.62%.
Earnings released on 4 Oct 2023
EPS came in at -$0.12 surpassing the estimated -$0.14 by +14.29%, while revenue for the quarter reached $78.68M , beating expectations by +1.27%.
Earnings released on 12 Jul 2023
EPS came in at $0.02 falling short of the estimated $0.02 by -11.11%, while revenue for the quarter reached $91.07M , beating expectations by +0.38%.
Earnings released on 30 Mar 2023
EPS came in at -$0.03 falling short of the estimated -$0.01 by -300.00%, while revenue for the quarter reached $80.71M , missing expectations by -11.46%.
Earnings released on 5 Jan 2023
EPS came in at $0.01 surpassing the estimated $0.00 by +200.30%, while revenue for the quarter reached $85.43M , beating expectations by +1.24%.
Earnings released on 6 Oct 2022
EPS came in at -$0.06 falling short of the estimated -$0.02 by -166.67%, while revenue for the quarter reached $81.54M , missing expectations by -2.27%.
Earnings released on 12 Jul 2022
EPS came in at $0.01 surpassing the estimated $0.01 by +33.33%, while revenue for the quarter reached $87.00M , beating expectations by +4.92%.
Earnings released on 7 Apr 2022
EPS came in at $0.03 surpassing the estimated $0.01 by +339.88%, while revenue for the quarter reached $73.97M , missing expectations by -3.08%.
Earnings released on 6 Jan 2022
EPS came in at -$0.02 falling short of the estimated -$0.00 by -481.40%, while revenue for the quarter reached $78.28M , beating expectations by +2.57%.
Earnings released on 30 Sept 2021
EPS came in at -$0.02 surpassing the estimated -$0.05 by +60.00%, while revenue for the quarter reached $76.97M , beating expectations by +7.94%.
Earnings released on 13 Jul 2021
EPS came in at -$0.51 , while revenue for the quarter reached $76.84M , beating expectations by +5.73%.
Earnings released on 30 Mar 2021
EPS came in at $0.02 surpassing the estimated $0.01 by +185.71%, while revenue for the quarter reached $71.18M , beating expectations by +3.24%.
Earnings released on 7 Jan 2021
EPS came in at $0.01 surpassing the estimated $0.00 by +150.00%, while revenue for the quarter reached $72.77M , missing expectations by -55.56%.
Earnings released on 29 Sept 2020
EPS came in at $0.02 surpassing the estimated -$0.06 by +133.33%, while revenue for the quarter reached $70.22M , missing expectations by -71.43%.
ANGO Stock Performance
Access detailed ANGO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.